SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950134-07-022175
Filing Date
2007-10-29
Accepted
2007-10-29 17:30:54
Documents
4
Group Members
HIGHLAND DISTRESSED OPPORTUNITIES INCHIGHLAND EQUITY OPPORTUNITIES FUNDHIGHLAND MULTI-STRATEGY MASTER FUND LPHIGHLAND MULTI-STRATEGY ONSHORE MASTER SUBFUND LLCJAMES DONDEROSTRAND ADVISORS INC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d50881sc13d.htm SC 13D 149020
2 JOINT FILING AGREEMENT d50881exv99w1.htm EX-99.1 17019
3 LETTER TO THE ISSUER d50881exv99w2.htm EX-99.2 20753
4 GRAPHIC d50881d5088100.gif GRAPHIC 4643
  Complete submission text file 0000950134-07-022175.txt   195584
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-43256 | Film No.: 071197393
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 13455 NOEL ROAD STE 1300 DALLAS TX 75240
Business Address 13455 NOEL ROAD STE 1300 DALLAS TX 75240 9726284100
HIGHLAND CAPITAL MANAGEMENT LP (Filed by) CIK: 0001167365 (see all company filings)

IRS No.: 752716725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D